scholarly journals Expression and Activation by Epstein Barr Virus of Human Endogenous Retroviruses-W in Blood Cells and Astrocytes: Inference for Multiple Sclerosis

PLoS ONE ◽  
2012 ◽  
Vol 7 (9) ◽  
pp. e44991 ◽  
Author(s):  
Giuseppe Mameli ◽  
Luciana Poddighe ◽  
Alessandra Mei ◽  
Elena Uleri ◽  
Stefano Sotgiu ◽  
...  
Author(s):  
Letícia Caroline Breis ◽  
Marco Antônio Machado Schlindwein ◽  
Marcus Vinicius Magno Gonçalves

Multiple Sclerosis (MS) has a well established link with Epstein-Barr virus (EBV) and a growing association with human endogenous retroviruses (HERVs). In this review, we described how these two pieces may interact in MS pathogenesis


2018 ◽  
Vol 24 (1) ◽  
pp. 42-47 ◽  
Author(s):  
Antonina Dolei

Two human endogenous retroviruses of the HERV-W family are proposed as multiple sclerosis (MS) co-factors: MS-associated retrovirus (MSRV) and ERVWE1, whose env proteins showed several potentially neuropathogenic features, in vitro and in animal models. Phase II clinical trials against HERV-Wenv are ongoing. HERV-W/MSRV was repeatedly found in MS patients, in striking parallel with MS stages, active/remission phases, and therapy outcome. The HERV-Wenv protein is highly expressed in active MS plaques. Early MSRV presence in spinal fluids predicted worst MS progression 10 years in advance. Effective anti-MS therapies strongly reduced MSRV/Syncytin-1/HERV-W expression. The Epstein–Barr virus (EBV) activates HERV-W/MSRV in vitro and in vivo, in patients with infectious mononucleosis and controls with high anti-EBNA1-IgG titers. Thus, the two main EBV/MS links (infectious mononucleosis and high anti-EBNA1-IgG titers) are paralleled by activation of HERV-W/MSRV. It is hypothesized that EBV may act as initial trigger of future MS, years later, by activating MSRV, which would act as direct neuropathogenic effector, before and during MS.


Viruses ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 643 ◽  
Author(s):  
Rachael E. Tarlinton ◽  
Ekaterina Martynova ◽  
Albert A. Rizvanov ◽  
Svetlana Khaiboullina ◽  
Subhash Verma

Multiple sclerosis (MS) is an immune inflammatory disease, where the underlying etiological cause remains elusive. Multiple triggering factors have been suggested, including environmental, genetic and gender components. However, underlying infectious triggers to the disease are also suspected. There is an increasing abundance of evidence supporting a viral etiology to MS, including the efficacy of interferon therapy and over-detection of viral antibodies and nucleic acids when compared with healthy patients. Several viruses have been proposed as potential triggering agents, including Epstein–Barr virus, human herpesvirus 6, varicella–zoster virus, cytomegalovirus, John Cunningham virus and human endogenous retroviruses. These viruses are all near ubiquitous and have a high prevalence in adult populations (or in the case of the retroviruses are actually part of the genome). They can establish lifelong infections with periods of reactivation, which may be linked to the relapsing nature of MS. In this review, the evidence for a role for viral infection in MS will be discussed with an emphasis on immune system activation related to MS disease pathogenesis.


PLoS ONE ◽  
2013 ◽  
Vol 8 (11) ◽  
pp. e78474 ◽  
Author(s):  
Giuseppe Mameli ◽  
Giordano Madeddu ◽  
Alessandra Mei ◽  
Elena Uleri ◽  
Luciana Poddighe ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document